NCT00827762 Behavioral Effects of Kuvan in Children With Mild Phenylketonuria Status TERMINATED Phase N/A
NCT00802893 Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction Status TERMINATED Phase PHASE2
NCT00789568 A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT00787995 A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome) Status TERMINATED Phase N/A
NCT00778206 PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry Status COMPLETED Phase N/A
NCT00728676 Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors Status COMPLETED Phase N/A
NCT00688844 Nutritional and Neurotransmitter Changes in PKU Subjects on BH4 Status COMPLETED Phase N/A
NCT00634660 Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria Status COMPLETED Phase PHASE1
NCT00625820 Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria Status COMPLETED Phase PHASE2
NCT00532844 A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction Status COMPLETED Phase PHASE2
NCT00445978 A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT00423280 Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study) Status UNKNOWN Phase PHASE2
NCT00403494 A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease Status COMPLETED Phase PHASE2
NCT00355264 Safety and Efficacy Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to BH4 Deficiency Status COMPLETED Phase PHASE2
NCT00332189 Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006 Status COMPLETED Phase PHASE3
NCT00325962 A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension Status COMPLETED Phase PHASE2
NCT00299000 A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI Status COMPLETED Phase PHASE4